Most patients undergoing ED cardioversion received guideline-concordant anticoagulation, but dosing variability and follow-up gaps remain, especially in low-risk patients.
Patients undergoing emergency department cardioversion for atrial fibrillation and flutter
Guideline-concordant anticoagulation, dosing variability, and revisit rates
While most ED cardioversion patients receive guideline-concordant anticoagulation, variability in post-procedural care and high revisit rates indicate a need for structured follow-up pathways.
Most patients undergoing ED cardioversion received guideline-concordant anticoagulation. However, variability in dosing and post-procedural therapy persists, particularly among low-risk patients. High revisit rates highlight the need for improved follow-up, continuity of anticoagulation, and structured care pathways following ED cardioversion.
Building similarity graph...
Analyzing shared references across papers
Loading...
Thomas Maouris
Peter Del Mar
Nathan J. Brown
Royal Brisbane and Women's Hospital
Princess Alexandra Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Maouris et al. (Wed,) reported a other. Most patients undergoing ED cardioversion received guideline-concordant anticoagulation, but dosing variability and follow-up gaps remain, especially in low-risk patients.
www.synapsesocial.com/papers/69a7ccb2d48f933b5eed86f5 — DOI: https://doi.org/10.1111/1742-6723.70231
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: